VECAMT: SUPERIOR CONTROL OF NIGHTTIME ACID SECRETION, TOWARDS A NOVEL TREATMENT FOR NIGHTTIME HEARTBURN

(1) Medical Director, Vecta Ltd

(2) Regulatory and Clinical Affairs

(3) Management

(4) Pre Clinical R&D

(5) Chemistry Unit, Vecta Ltd., Kfar-Saba, Israel

(6) Clinical Services

(7) Principal Investigator, Clinical Applications Laboratories Inc., San Diego, CA

(8) Department of Medicine, University of Arizona, Tucson, AZ, United States



This item was part of the OESOPHAGEAL, GASTRIC AND DUODENAL DISORDERS II session at Gastro 2009 UEGW/WCOG London (17th UEGW)

Categorisation:

  • Format
    • Poster
  • Language
    • English
  • Year
    • 2009